#373 Digitising Pathology: Why AI is the Future of Cancer Treatment with Meriem Sefta from Owkin

This week, James is joined by Dr. Meriem Sefta, PhD, Chief Diagnostics Officer at Owkin. Owkin is the first end-to-end AI-biotech company on a mission to understand complex biology and ensure every patient gets the right treatment using AI trained on world-class patient data through privacy-enhancing technologies.Learn more: https://www.owkin.com/diagnostics-approachApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health